Folgen
Marc Lipman
Marc Lipman
Professor of Medicine, University College London & Royal Free London NHS Foundation Trust
Bestätigte E-Mail-Adresse bei nhs.net
Titel
Zitiert von
Zitiert von
Jahr
Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials
P Mangtani, I Abubakar, C Ariti, R Beynon, L Pimpin, PEM Fine, ...
Clinical infectious diseases 58 (4), 470-480, 2014
10102014
‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19
S Mandal, J Barnett, SE Brill, JS Brown, EK Denneny, SS Hare, ...
Thorax 76 (4), 396-398, 2021
9022021
Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis
M Sester, G Sotgiu, C Lange, C Giehl, E Girardi, GB Migliori, A Bossink, ...
European Respiratory Journal 37 (1), 100-111, 2011
7302011
Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection
RAM Breen, CJ Smith, H Bettinson, S Dart, B Bannister, MA Johnson, ...
Thorax 59 (8), 704-707, 2004
4602004
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study
RA Evans, H McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ...
The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021
4562021
Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis.
I Abubakar, L Pimpin, C Ariti, R Beynon, P Mangtani, JAC Sterne, ...
Health technology assessment (Winchester, England) 17 (37), 1, 2013
3732013
Drug-resistant tuberculosis: time for visionary political leadership
I Abubakar, M Zignol, D Falzon, M Raviglione, L Ditiu, S Masham, I Adetifa, ...
The Lancet infectious diseases 13 (6), 529-539, 2013
3612013
Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers
CI Bloom, CM Graham, MPR Berry, F Rozakeas, PS Redford, Y Wang, ...
PloS one 8 (8), e70630, 2013
3302013
Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy
K Dheda, FC Lampe, MA Johnson, MC Lipman
Journal of Infectious Diseases 190 (9), 1670-1676, 2004
2912004
Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America
Antiretroviral Therapy Cohort Collaboration
Clinical Infectious Diseases 41 (12), 1772-1782, 2005
2822005
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study
RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ...
The Lancet Respiratory Medicine 10 (8), 761-775, 2022
2772022
MMP-1 drives immunopathology in human tuberculosis and transgenic mice
P Elkington, T Shiomi, R Breen, RK Nuttall, CA Ugarte-Gil, NF Walker, ...
The Journal of clinical investigation 121 (5), 1827-1833, 2011
2712011
Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes
T Togun, B Kampmann, NG Stoker, M Lipman
Annals of clinical microbiology and antimicrobials 19, 1-6, 2020
2692020
Immune reconstitution and “unmasking” of tuberculosis during antiretroviral therapy
SD Lawn, RJ Wilkinson, MCI Lipman, R Wood
American journal of respiratory and critical care medicine 177 (7), 680-685, 2008
2542008
Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28− T cells
NJ Borthwick, M Bofill, WM Gombert, AN Akbar, E Medina, K Sagawa, ...
Aids 8 (4), 431-442, 1994
2391994
Adverse events and treatment interruption in tuberculosis patients with and without HIV co-infection
RAM Breen, RF Miller, T Gorsuch, CJ Smith, A Schwenk, W Holmes, ...
Thorax 61 (9), 791-794, 2006
2372006
Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial
A Story, RW Aldridge, CM Smith, E Garber, J Hall, G Ferenando, L Possas, ...
The Lancet 393 (10177), 1216-1224, 2019
2272019
The transmission of Mycobacterium tuberculosis in high burden settings
TA Yates, PY Khan, GM Knight, JG Taylor, TD McHugh, M Lipman, ...
The Lancet infectious diseases 16 (2), 227-238, 2016
2262016
Treatment of latent tuberculosis infection: an updated network meta-analysis
D Zenner, N Beer, RJ Harris, MC Lipman, HR Stagg, MJ Van Der Werf
Annals of internal medicine 167 (4), 248-255, 2017
2242017
Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy
CI Bloom, CM Graham, MPR Berry, KA Wilkinson, T Oni, F Rozakeas, ...
Public Library of Science 7 (10), e46191, 2012
2212012
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20